Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $113.38 | $25.68 | 341.53% | 213.92x | 53.96x | 14.38x | 17.37x | 1.55x | $106.92M | 0.90% | $705.78M | 6.70 | $12.15B | 1,549.34 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.75 | $8.73 | 171.93% | 113.10x | 55.23x | 6.68x | 13.53x | 0.97x | $39.15M | 1.26% | $220.58M | 1.69 | $3.06B | 67.52 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $246.11 | $84.69 | 190.60% | 40.35x | 36.28x | 6.84x | 24.32x | 1.42x | $793.95M | 2.41% | $1.35B | 10.14 | $34.21B | 29.01 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.28 | $18.50 | 328.54% | 74.09x | 67.82x | 7.31x | 9.46x | 1.89x | $182.84M | 2.97% | $654.15M | 8.43 | $6.02B | 50.18 | ||
| HALO | HALOZYME THERAPEUTICS INC | $107.72 | $72.52 | 48.54% | 30.26x | 11.93x | 7.59x | 85.17x | 0.62x | $806.22M | 6.38% | $143.54M | 1.22 | $14.21B | 19.78 | ||
| VCEL | VERICEL CORP | $40.50 | $8.54 | 374.25% | 84.38x | 72.36x | 6.75x | 5.60x | 2.07x | $61.66M | 2.98% | $370.04M | 7.25 | $2.04B | 46.34 | ||
| RPRX | ROYALTY PHARMA PLC | $62.32 | $38.46 | 62.02% | 33.15x | 11.64x | 10.94x | 3.66x | 0.67x | $2.92B | 10.54% | $9.79B | 21.99 | $43.98B | 37.40 | ||
| KRYS | KRYSTAL BIOTECH INC | $363.84 | $90.03 | 304.11% | 44.00x | 46.61x | 24.39x | 7.92x | 2.33x | $257.78M | 2.40% | $1.36B | 46.03 | $10.35B | 44.37 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $64.84 | $20.12 | 222.28% | 170.63x | 22.27x | 3.68x | 1.99x | 1.12x | $738.18M | 5.89% | $6.32B | 32.68 | $15.86B | 41.13 | ||
| TECH | BIO-TECHNE CORP | $72.18 | $17.50 | 312.43% | 61.69x | 34.57x | 9.26x | 5.37x | 1.94x | $263.22M | 2.34% | $2.11B | 13.52 | $11.34B | 32.63 | ||
| TGTX | TG THERAPEUTICS INC | $56.09 | $23.95 | 134.22% | 18.21x | 56.44x | 9.95x | 14.21x | 2.03x | $17.39M | 0.22% | $604.08M | 4.26 | $8.85B | 63.60 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.06 | $8.13 | 48.34% | 12.69x | 11.08x | 5.24x | 3.29x | 1.11x | $82.01M | 11.49% | $217.65M | 3.68 | $572.34M | 7.40 | ||
| ADMA | ADMA BIOLOGICS INC | $9.33 | $7.45 | 25.18% | 12.96x | 11.73x | 4.16x | 5.12x | 0.76x | $116.47M | 5.47% | $408.21M | 1.79 | $2.15B | 9.23 | ||
| EXEL | EXELIXIS INC | $56.89 | $32.01 | 77.75% | 17.29x | 17.23x | 5.86x | 7.65x | 1.14x | $1.17B | 8.22% | $1.84B | 7.35 | $13.98B | 12.85 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $284.27 | $91.79 | 209.68% | 28.23x | 30.09x | 19.63x | 5.86x | 2.13x | $130.62M | 2.29% | $967.52M | 48.22 | $5.79B | 20.76 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.71 | $190.13 | 28.18% | 15.97x | 9.54x | 3.35x | 3.29x | 0.67x | $1.62B | 10.51% | $4.80B | 75.98 | $18.60B | 11.50 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $6.35 | -81.10% | 8.57x | -4.06x | 1.48x | 1.58x | 0.07x | $19.58M | 28.17% | $44.20M | 0.76 | $21.15M | 2.77 | ||
| MDXG | MIMEDX GROUP INC | $4.52 | $1.52 | 196.87% | 113.00x | -32.22x | 1.88x | 3.05x | 1.08x | $44.50M | 6.66% | $216.00M | 1.46 | $540.20M | 23.68 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.65 | $162.55 | 236.90% | 31.60x | 28.49x | 11.04x | 6.86x | 2.25x | $3.80B | 2.73% | $20.25B | 79.81 | $134.64B | 24.47 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $823.82 | $455.66 | 80.80% | 19.64x | 14.77x | 5.45x | 2.67x | 1.05x | $3.76B | 4.44% | $31.71B | 308.48 | $85.07B | 14.79 | ||
| UTHR | UNITED THERAPEUTICS CORP | $512.70 | $204.64 | 150.54% | 16.95x | 19.14x | 6.92x | 3.44x | 2.93x | $1.09B | 5.00% | $6.40B | 150.24 | $20.19B | 12.04 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.25 | $32.15 | 28.32% | 13.14x | 9.90x | 2.49x | 2.40x | 0.78x | $354.90M | 14.85% | $999.24M | 17.25 | $2.01B | 7.17 | ||
| INCY | INCYTE CORP | $125.01 | $62.93 | 98.66% | 15.40x | 35.26x | 4.30x | 3.99x | 1.73x | $1.92B | 7.67% | $6.34B | 31.66 | $21.39B | 10.34 | ||
| VCYT | VERACYTE INC | $43.43 | $7.23 | 500.42% | 30.16x | 41.54x | 6.18x | 2.51x | 119.96x | $165.99M | 4.78% | $1.39B | 17.36 | $3.23B | 23.13 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.